Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (786)	4/10/2003 8:11:35 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 3557

Strange, May 9, is far away. Bottom price that Novartis will pay was 20/share. Page 1 of 4 Pages -------------------------------------------------------------------------------- CUSIP No. 75886F107 -------------------------------------------------------------------------------- (1) Names and I.R.S. Identification Nos.(entities only) of reporting persons. Novartis Pharma AG 00-0000000 -------------------------------------------------------------------------------- (2) Check the appropriate box if a member of a group (see instructions) (a)\|_\| (b)\|_\| -------------------------------------------------------------------------------- (3) SEC use only. -------------------------------------------------------------------------------- (4) Citizenship or place of organization. Switzerland -------------------------------------------------------------------------------- Number of shares beneficially owned by each reporting person with: (5) Sole voting power: 2,400,000 (6) Shared voting power: 0 (7) Sole dispositive power: 2,400,000 (8) Shared dispositive power: 0